6KX2 image
Entry Detail
PDB ID:
6KX2
Keywords:
Title:
Crystal structure of GDP bound RhoA protein
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-09-09
Release Date:
2020-08-19
Method Details:
Experimental Method:
Resolution:
1.45 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Transforming protein RhoA
Mutations:C16V, C20S, C83V, C159T
Chain IDs:A
Chain Length:181
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.
Adv Sci 7 2000098 2000098 (2020)
PMID: 32714746 DOI: 10.1002/advs.202000098

Abstact

The Rho family GTPases are crucial drivers of tumor growth and metastasis. However, it is difficult to develop GTPases inhibitors due to a lack of well-characterized binding pockets for compounds. Here, through molecular dynamics simulation of the RhoA protein, a groove around cysteine 107 (Cys107) that is relatively well-conserved within the Rho family is discovered. Using a combined strategy, the novel inhibitor DC-Rhoin is discovered, which disrupts interaction of Rho proteins with guanine nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors (GDIs). Crystallographic studies reveal that the covalent binding of DC-Rhoin to the Cys107 residue stabilizes and captures a novel allosteric pocket. Moreover, the derivative compound DC-Rhoin04 inhibits the migration and invasion of cancer cells, through targeting this allosteric pocket of RhoA. The study reveals a novel allosteric regulatory site within the Rho family, which can be exploited for anti-metastasis drug development, and also provides a novel strategy for inhibitor discovery toward "undruggable" protein targets.

Legend

Protein

Chemical

Disease

Primary Citation of related structures